Infections in patients with rheumatoid arthritis treated with biologic agents.

By J. Listing, A. Strangfeld, S. Kary, R. Rau, U. von Hinueber, M. Stoyanova-Scholz, E. Gromnica-Ihle, C. Antoni, P. Herzer, J. Kekow and 2 more. Arthritis & Rheumatism, 2005

723 citations recorded by the source corpus.

Subfields: Hematology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/4ba06a29e1b5d9c61a70c45ecfbcd95e8bfca63a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. G. Palmer
2. C. Gabay
3. K. Ren
4. R. Dubner
5. W. Arend

Citations in the corpus

• IL‐1, IL‐18, and IL‐33 families of cytokines (2008, background): “An increased rate of infections has been reported with the use of TNF antagonists, a cytokine also involved in host responses to microorganisms (165).”
• Interactions between the immune and nervous systems in pain (2010, background): “Kineret (anakinra, Amgen), a recombinant human IL-1 receptor antagonist (IL-1ra), and two TNF inhibitors, Enbrel (etanercept, Pfizer and Amgen) and Remicade (infliximab, Centoco), inhibit the pain associated with rheumatoid arthritis and other inflammatory condition”